- Home
- Publications
- Publication Search
- Publication Details
Title
Post-acute management of the acquired long QT syndrome
Authors
Keywords
-
Journal
POSTGRADUATE MEDICAL JOURNAL
Volume 90, Issue 1064, Pages 348-358
Publisher
BMJ
Online
2014-04-03
DOI
10.1136/postgradmedj-2013-132398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Slow Delayed Rectifier Potassium Current Blockade Contributes Importantly to Drug-Induced Long QT Syndrome
- (2013) Christiaan C. Veerman et al. Circulation-Arrhythmia and Electrophysiology
- Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives
- (2013) Saagar Mahida et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs
- (2012) James E. Tisdale et al. DRUG SAFETY
- Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations
- (2012) Mitsunori Maruyama et al. HEART RHYTHM
- Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia
- (2012) Yalda Jamshidi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality
- (2011) David Pickham et al. CRITICAL CARE MEDICINE
- Electrocardiographic QT Interval and Mortality
- (2011) Yiyi Zhang et al. EPIDEMIOLOGY
- Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: A long-term follow-up
- (2011) G. Monnig et al. EUROPACE
- A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure
- (2011) Gerrit Frommeyer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers
- (2011) Prince J. Kannankeril et al. HEART RHYTHM
- Prevalence and determinants of QT interval prolongation in medical inpatients
- (2011) M. Pasquier et al. INTERNAL MEDICINE JOURNAL
- Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?
- (2010) Peter J. Schwartz et al. CIRCULATION
- Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome
- (2010) Kayo Haraoka et al. HEART RHYTHM
- In-hospital prescription of QT-prolonging drugs in a cohort of more than 100,000 patients
- (2010) Rui Baptista et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome
- (2009) Paulus Kirchhof et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening?
- (2009) Rob Towart et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome
- (2008) Thomas G. Diness et al. CARDIOVASCULAR RESEARCH
- Repolarization Reserve
- (2008) Dan M. Roden CIRCULATION
- Persistent Atrial Fibrillation Is Associated With Reduced Risk of Torsades de Pointes in Patients With Drug-Induced Long QT Syndrome
- (2008) Dawood Darbar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long QT Syndrome
- (2008) Ilan Goldenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes
- (2007) Konstantinos P. Letsas et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More